Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Resiliency Training for Patients With NF2 Via Videoconferencing With Skype

NCT02811718
completednot_applicable

Resiliency Training for Adolescent Neurofibromatosis Patients Via Videoconferencing With Skype

NCT02387177
completednot_applicable

Quantification of Outcome Measures for Mind-body Interventions

NCT01308970

Clinical Trials (3)

Showing 3 of 3 trials
NCT02811718Not Applicable

Resiliency Training for Patients With NF2 Via Videoconferencing With Skype

Completed
NCT02387177Not Applicable

Resiliency Training for Adolescent Neurofibromatosis Patients Via Videoconferencing With Skype

Completed
NCT01308970Not Applicable

Quantification of Outcome Measures for Mind-body Interventions

Completed

All 3 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
3